Group EMDR for the treatment of patients with complex post-traumatic stress disorder - side effects and autobiographic memory

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00039891

Enrollment

Registered

2026-05-08

Start date

2026-05-08

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

complex posttraumatic stress disorder

Interventions

Group 1: Trauma confrontative treatment through EMDR in the group with the help of the G-TEP protocol (Group Traumatic Episode Protocol) according to Shapiro. 5 outpatient sessions, 1 individual follo

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Complex Posttraumatic Stress Disorder

Exclusion criteria

Exclusion criteria: acute suicidal tendencies, substance abuse, psychotic symptoms, individual exclusion criteria, which are asked about in a detailed interview before inclusion in the study (strategies for emotion regulation, self-injurious behavior, dissociations, previous therapeutic experience, medication, outpatient therapeutic connection, etc.)

Design outcomes

Primary

Measure	Time frame
Symptom burden of complex post-traumatic stress disorder, measured with the International Trauma Questionnaire (ITQ), as well as unwanted side effects measured with the Negative Effects Questionnaire (NEQ-32). Data collection before the first session (T1), after the last session (T2) and 6 weeks after T2 (T3). Changes in autobiographical memories, as assessed using the Autobiographical Memory Test (AMT) before the first session and after the final session.	—

Measure

Time frame

Symptom burden of complex post-traumatic stress disorder, measured with the International Trauma Questionnaire (ITQ), as well as unwanted side effects measured with the Negative Effects Questionnaire (NEQ-32). Data collection before the first session (T1), after the last session (T2) and 6 weeks after T2 (T3). Changes in autobiographical memories, as assessed using the Autobiographical Memory Test (AMT) before the first session and after the final session.

—

Secondary

Measure	Time frame
Symptom burden of depressive and anxiety symptoms (recorded with the PHQ-9, GAD-7), dissociative symptoms (questionnaire on dissociative symptoms, FDS), symptoms of somatic stress disorder according to DSM-V (measured with the SSD-12) and recording of emotion regulation (Emotion Regulation Questionnaire, ERQ). Data collection points such as primary outcome at T1, T2, T3. Assessment of traumatic experiences in childhood/adolescence using the Childhood Trauma Questionnaire (CTQ) at T1.	—

Measure

Time frame

Symptom burden of depressive and anxiety symptoms (recorded with the PHQ-9, GAD-7), dissociative symptoms (questionnaire on dissociative symptoms, FDS), symptoms of somatic stress disorder according to DSM-V (measured with the SSD-12) and recording of emotion regulation (Emotion Regulation Questionnaire, ERQ). Data collection points such as primary outcome at T1, T2, T3. Assessment of traumatic experiences in childhood/adolescence using the Childhood Trauma Questionnaire (CTQ) at T1.

—

Countries

Germany

Contacts

Public ContactIrja Rzepka-Marot

Universitätsklinikum Heidelberg

irja.rzepka-marot@med.uni-heidelberg.de+4962215634453

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026